Dr. Glynis Ablon, M.D

NPI: 1144292889
Total Payments
$111,781
2024 Payments
$39,631
Companies
39
Transactions
449

Payment Breakdown by Category

Consulting$48,425 (43.3%)
Research$45,233 (40.5%)
Food & Beverage$9,936 (8.9%)
Travel$4,775 (4.3%)
Other$3,300 (3.0%)
Education$111.95 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $48,425 12 43.3%
Unspecified $45,233 11 40.5%
Food and Beverage $9,936 398 8.9%
Travel and Lodging $4,775 22 4.3%
Honoraria $2,000 1 1.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,300 1 1.2%
Education $111.95 4 0.1%

Payments by Type

General
$66,548
438 transactions
Research
$45,233
11 transactions

Top Paying Companies

Company Total Records Latest Year
Galderma Laboratories, L.P. $78,609 129 $0 (2024)
Bausch Health US, LLC $7,328 3 $0 (2021)
Ipsen Innovation $4,505 3 $0 (2020)
STRATA Skin Sciences, Inc. $4,041 3 $0 (2023)
DERMIRA, INC. $3,081 9 $0 (2020)
Almirall LLC $2,817 11 $0 (2024)
PFIZER INC. $2,172 30 $0 (2024)
Sensus Healthcare, Inc. $2,107 2 $0 (2018)
Valeant Pharmaceuticals North America LLC $1,440 2 $0 (2017)
MAYNE PHARMA INC. $1,003 76 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $39,631 53 Galderma Laboratories, L.P. ($38,580)
2023 $37,279 90 Galderma Laboratories, L.P. ($30,294)
2022 $987.33 31 Galderma Laboratories, L.P. ($364.41)
2021 $10,403 45 Bausch Health US, LLC ($7,328)
2020 $7,416 36 Ipsen Innovation ($4,505)
2019 $3,530 29 DERMIRA, INC. ($3,012)
2018 $9,975 90 Galderma Laboratories, L.P. ($4,404)
2017 $2,561 75 Valeant Pharmaceuticals North America LLC ($1,440)

All Payment Transactions

449 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
11/20/2024 Journey Medical Corporation Food and Beverage In-kind items and services $24.06 General
11/13/2024 Galderma Laboratories, L.P. Consulting Fee Cash or cash equivalent $1,700.00 General
11/08/2024 Galderma Laboratories, L.P. Cash or cash equivalent $690.80 Research
Study: 43BBJ1911
11/08/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $9.58 General
10/26/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $157.56 General
10/23/2024 Ortho Dermatologics, a division of Bausch Health US, LLC Cabtreo (Drug), JUBLIA Food and Beverage In-kind items and services $20.22 General
Category: Dermatology
10/19/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $4.04 General
10/18/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $9.52 General
10/01/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $28.19 General
Category: Dermatology
09/17/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $15.25 General
Category: AESTHETICS AND THERAPEUTICS
09/13/2024 Galderma Laboratories, L.P. Cash or cash equivalent $5,852.00 Research
Study: 43BBJ1911
09/09/2024 SUN PHARMACEUTICAL INDUSTRIES INC. BLU-U (Medical Supply), Odomzo Food and Beverage In-kind items and services $28.23 General
Category: Dermatology
08/29/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $25.32 General
Category: Immunology
08/28/2024 Galderma Laboratories, L.P. DYSPORT (Biological) Food and Beverage In-kind items and services $11.28 General
08/28/2024 Galderma Laboratories, L.P. DYSPORT (Biological) Food and Beverage In-kind items and services $0.98 General
08/16/2024 Galderma Laboratories, L.P. Cash or cash equivalent $10,566.80 Research
Study: 43BBJ1911
08/09/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $23.65 General
Category: AESTHETICS AND THERAPEUTICS
07/31/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $9.28 General
07/16/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $3.33 General
07/12/2024 Galderma Laboratories, L.P. Cash or cash equivalent $2,307.20 Research
Study: 43BBJ1911
06/21/2024 Galderma Laboratories, L.P. Cash or cash equivalent $12,580.20 Research
Study: 43BBJ1911
06/19/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $8.85 General
05/23/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $26.20 General
Category: AESTHETICS AND THERAPEUTICS
05/22/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $18.27 General
05/16/2024 ABBVIE INC. Food and Beverage In-kind items and services $150.00 General

Research Studies & Clinical Trials

Study Name Company Amount Records
43BBJ1911 Galderma Laboratories, L.P. $36,411 6
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS Bausch Health US, LLC $7,283 2
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris Valeant Pharmaceuticals North America LLC $1,440 2
A LONG-TERM STUDY TO ASSESS THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS Eli Lilly and Company $99.59 1

About Dr. Glynis Ablon, M.D

Dr. Glynis Ablon, M.D is a Dermatology healthcare provider based in Manhattan Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144292889.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glynis Ablon, M.D has received a total of $111,781 in payments from pharmaceutical and medical device companies, with $39,631 received in 2024. These payments were reported across 449 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($48,425).

Practice Information

  • Specialty Dermatology
  • Location Manhattan Beach, CA
  • Active Since 02/06/2006
  • Last Updated 02/19/2008
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1144292889

Products in Payments

  • DYSPORT (Drug) $4,505
  • XTRAC (Device) $4,041
  • QBREXZA (Drug) $3,055
  • LITFULO (Drug) $1,595
  • DORYX (Drug) $788.11
  • Xeomin (Biological) $690.64
  • EUCRISA (Drug) $476.56
  • ENSTILAR (Drug) $322.05
  • OPZELURA (Drug) $280.17
  • TREMFYA (Drug) $202.90
  • FABIOR (Drug) $179.25
  • Ecoza (Drug) $135.28
  • JUBLIA (Drug) $129.73
  • Seysara (Drug) $126.34
  • Winlevi (Drug) $121.22
  • AKLIEF (Drug) $116.56
  • CLODERM (Drug) $115.07
  • ORACEA (Drug) $109.70
  • XEOMIN (Biological) $107.37
  • COSENTYX (Drug) $104.06

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Manhattan Beach